Objective: To examine the efficacy of octreotide in resolving chylothoraces in infants and children following cardiac surgery.
Design: Retrospective chart review.
Setting: Pediatric intensive care unit of a tertiary care center.
Patients: All children who received octreotide for the treatment of chylothoraces following surgery for congenital heart disease over a 30-month period between 2001-2004.
Interventions: Octreotide infusion.
Measurements And Main Results: Eight courses of octreotide treatment were identified in seven patients who met our inclusion criteria. The median duration of therapy was 5 days, and dosing ranged from 1 to 4 microg/kg/hr. Treatment did not result in an overall decrease in average chest tube output after 3 days of therapy. However, in two patients (29%) the chylothoraces ultimately resolved during the octreotide infusion. Treatment was well tolerated, and no serious side effects were noted.
Conclusion: In contrast to previously published reports, we find octreotide therapy for postoperative chylothoraces to be successful in only a minority of cases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/01.PCC.0000216683.00110.0E | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pneumonectomy Space Infection After Thoracic Duct Embolization.
Ann Thorac Surg Short Rep
June 2024
Division of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin.
Thoracic duct embolization has gained widespread acceptance as an effective treatment of postoperative chylothorax. We describe a patient with chylothorax after pneumonectomy requiring thoracic duct embolization who presented again with a pneumonectomy space infection. Bacterial culture was positive for gastrointestinal flora, which suggests that the pleural space was inoculated at the time of thoracic duct embolization.
View Article and Find Full Text PDFSternotomy or thoracotomy for neonatal repair of coarctation of the aorta with aortic arch hypoplasia.
JTCVS Open
December 2024
Department of Cardiac Surgery, Boston Children's Hospital, Boston, Mass.
Objective: For neonatal repair of coarctation of the aorta, patients may either undergo thoracotomy with extended end-to-end anastomosis or sternotomy for aortic arch reconstruction with cardiopulmonary bypass. The objective of this study was to evaluate the comparative effectiveness of the 2 approaches in patients with arch hypoplasia.
Methods: This is a single-center retrospective cohort study from July 2005 through May 2022 of patients who underwent neonatal repair for isolated coarctation of the aorta with additional arch hypoplasia.
Imaging and Clinical Features of Primary Thoracic Lymphangioma.
Curr Med Imaging
January 2025
Department of Radiology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Background: Primary thoracic lymphangioma is a rare disease. Most of the previous studies are comprised of individual case reports, with a very limited number of patients included.
Objective: This study aims to investigate the chest computed tomography (CT) imaging features and clinical manifestations of thoracic lymphangioma, thereby enhancing our understanding of the condition.
Comparison of mediastinoscopy and thoracoscope minimally invasive esophagectomy in the treatment of esophageal cancer: a meta-analysis and system review.
BMC Cancer
January 2025
Department of Thoracic Surgery, the Second Hospital of Jilin University, Changchun, China.
Objective: The efficacy and safety of transcervical inflatable mediastinoscopic esophagectomy (TIME) in the treatment of esophageal cancer are unclear. The objective of this meta-analysis was to evaluate the efficacy and safety of TIME treatment for esophageal cancer and to compare it with thoracoscopic assisted minimally invasive esophagectomy (TAMIE) for the treatment of esophageal cancer.
Methods: A literature search was performed using PubMed, Embase, and the Cochrane Library to retrieve articles published up to January 2024 to comparatively assess studies of TIME and TAMIE.
Retrograde thoracic duct embolization in an idiopathic case of chylopericardium.
J Cardiothorac Surg
January 2025
Department of Cardiothoracic Surgery, Queen Elizabeth Hospital, King's Park, Hong Kong.
This is a novel case of idiopathic chylopericardium and chylothorax in a young male who had no significant medical history. He first presented with dyspnea due to idiopathic chylopericardium, which was refractory to medical and surgical treatments, including a medium-chain triglyceride diet, octreotide, and video-assisted pericardial window. The chylopericardium persisted and progressed to concomitant left-sided chylothorax.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!